Source: BioSpace

CorDynamics: Sinclair Research Announces Expansion into Safety Pharmacology Services with CorDynamics Partnership

Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets of the GLP safety pharmacology business unit of CorDynamics, a premier provider of cardiovascular toxicology and safety pharmacology contract research services.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

Co-Founder & CEO

Michael R. Gralinski

CEO Approval Rating

- -/100

Read more